Riskpilot← Back to searchSign inGet full accessOnego Bio Ltd
OYActiveY-tunnus 3260781-9Hämeentie 157Research and experimental development on natural sciences and engineering · NACE 7210Est. 202231 employees
Revenue 2024
EUR 0
EBITDA margin
—
-224% vs 2023
Equity ratio
59.1%
Financial strength
Net profit 2024
EUR -9,4M
-185% vs 2023
| Revenue | EUR 0 | — |
| EBITDA | EUR -9M | -224% |
| Net profit | EUR -9,4M | -185% |
| Total assets | EUR 34,1M | +216% |
| Equity | EUR 20,1M | +137% |
| Employees | 31 | — |
Legal name
Onego Bio Ltd
Y-tunnus number
3260781-9
Legal form
Osakeyhtiö
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
13. tammikuuta 2022
Share capital
EUR 0
Employees
31 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on biotekninen tutkimus ja kehittäminen (72110)
Address
Hämeentie 157
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 0 | 3 170 | 0 |
| Staff expenses | −850 | −1 576 | −2 473 |
| EBITDA | −1 324 | −2 767 | −8 962 |
| Depreciation & amort. | −274 | −544 | −712 |
| EBIT | −1 597 | −3 310 | −9 674 |
| Net financials | 0 | −1 | 227 |
| Profit before tax | −1 597 | −3 311 | −9 447 |
| Tax | −0 | −0 | −0 |
| Net profit | −1 597 | −3 311 | −9 447 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 13 094 | 10 808 | 34 113 |
| Equity | 11 603 | 8 491 | 20 145 |
| Long-term debt | — | 0 | 11 872 |
| Short-term debt | 1 491 | 2 317 | 2 096 |
| Total debt | 1 491 | 2 317 | 13 968 |
EBITDA margin
-896208400.0%
This company
15.8%
Market median
-5672205163% vs market
20222024
Equity ratio
59.1%
This company
38.2%
Market median
+55% vs market
20222024
Return on equity
-46.9%
This company
18.4%
Market median
-355% vs market
20222024
Net profit margin
-944669700.0%
This company
8.1%
Market median
-11662588989% vs market
20222024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222024
Debt / equity
0.69×
This company
0.62×
Market median
+11% vs market
20222024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MV Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
AA Confidential Clerk | Confidential Clerk | 2024 | — | — |
TP Confidential Clerk | Confidential Clerk | 2024 | — | — |
OP Audit | Audit | 2022 | — | — |
TJ Deputy auditor | Deputy auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairperson | 2022 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairperson | 2024 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2024 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Onego Bio Ltd also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maija Vilhelmiina Itkonen | Chief Executive Officer | 0 companies |
| Anna-Mari Annikki Saari | Confidential Clerk | 0 companies |
| Thomas Paul Ferguson | Confidential Clerk | 0 companies |
| Otto-Einari Pyykönen | Audit | 0 companies |
| Tom Jonas Sandell | Deputy auditor | 0 companies |
| Jussi Joonas Joensuu | Chairperson | 0 companies |
| Philip Boigner | Board of Directors | 0 companies |
| Tomosaku Sohara | Board of Directors | 0 companies |
| Paavo Eero Salminen | Chairperson | 0 companies |
| Antti Henrik Alex Vasara | Board of Directors | 0 companies |
| Paavo Johannes Räisänen | Board of Directors | 0 companies |
| Anthony Matthew Chow | Board of Directors | 0 companies |
| Christopher Paul Landowski | Board of Directors | 0 companies |